XT
CPHI icon

XTX Topco’s China Pharma Holdings CPHI Stock Holding History

XTX Topco’s Portfolio CPHI Stock Details CPHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8,379
Closed -$22K – 2480
2025
Q1 		$22K Buy
8,379
+1,667
+25% +$3.81K ﹤0.01% 2121
2024
Q4 		$15.6K Buy
6,712
+4,553
+211% +$9.86K ﹤0.01% 2084
2024
Q3 		$5.1K Sell
2,159
-715
-25% -$1.58K ﹤0.01% 1978
2024
Q2 		$7.14K Buy
+2,874
New +$8.82K ﹤0.01% 1720

Other funds holding CPHI

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

XTX Topco's CPHI Position: Q2 2025 in Review

XTX Topco sold out of China Pharma Holdings (CPHI) in Q2 2025, closing a stake of 8,379 shares — an estimated $22K sold.

XTX Topco first reported a position in CPHI in Q2 2024 and held it in 4 quarters. The position peaked at $22K in Q1 2025. 5 funds tracked by Wall St. Rank hold CPHI as of Q2 2025.

  • XTX Topco reported no remaining China Pharma Holdings position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 8,379 China Pharma Holdings shares in Q2 2025, an estimated $22K.
  • XTX Topco first reported a position in China Pharma Holdings in Q2 2024 and held it in 4 quarters.
  • XTX Topco's China Pharma Holdings position peaked at $22K in Q1 2025.
  • 5 funds tracked by Wall St. Rank held China Pharma Holdings as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.